Clearpoint Neuro, Inc.

Clearpoint Neuro, Inc. company information, Employees & Contact Information

ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ClearPoint Neuro is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.
Looking for a particular Clearpoint Neuro, Inc. employee's phone or email?

Clearpoint Neuro, Inc. Questions

News

Revolutionary Robot-Guided Brain Navigation System: ClearPoint Neuro's New Platform for Gene Therapy Delivery - Stock Titan

Revolutionary Robot-Guided Brain Navigation System: ClearPoint Neuro's New Platform for Gene Therapy Delivery Stock Titan

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - ACCESS Newswire

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles ACCESS Newswire

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room - FinancialContent

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room FinancialContent

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide ACCESS Newswire

ClearPoint Neuro to Present Q2 2025 Financial Results August 12 - Live Call Details Inside - Stock Titan

ClearPoint Neuro to Present Q2 2025 Financial Results August 12 - Live Call Details Inside Stock Titan

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 - Yahoo Finance

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 Yahoo Finance

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - ACCESS Newswire

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System ACCESS Newswire

ClearPoint Neuro Announces Full Market Release of - GlobeNewswire

ClearPoint Neuro Announces Full Market Release of GlobeNewswire

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons - PR Newswire

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons PR Newswire

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency - Yahoo Finance

ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency Yahoo Finance

ClearPoint Neuro Congratulates its Partner PTC Therapeutics - GlobeNewswire

ClearPoint Neuro Congratulates its Partner PTC Therapeutics GlobeNewswire

ClearPoint Neuro Makes History with First FDA-Approved Brain Gene Therapy Device - Stock Titan

ClearPoint Neuro Makes History with First FDA-Approved Brain Gene Therapy Device Stock Titan

ClearPoint Neuro and Higgs Boson Health Announce Collaboration - GlobeNewswire

ClearPoint Neuro and Higgs Boson Health Announce Collaboration GlobeNewswire

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - ACCESS Newswire

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain ACCESS Newswire

34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan

34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions Stock Titan

ClearPoint Neuro, Inc. Announces First-in-Human Cases of - GlobeNewswire

ClearPoint Neuro, Inc. Announces First-in-Human Cases of GlobeNewswire

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer - ACCESS Newswire

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer ACCESS Newswire

Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan

Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease Stock Titan

ClearPoint Neuro FDA Filing Could Double Market Access for Laser Therapy System | CLPT Stock News - Stock Titan

ClearPoint Neuro FDA Filing Could Double Market Access for Laser Therapy System | CLPT Stock News Stock Titan

ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients - Yahoo Finance

ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients Yahoo Finance

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1 - GlobeNewswire

ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1 GlobeNewswire

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe - GlobeNewswire

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe GlobeNewswire

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics - GlobeNewswire

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics GlobeNewswire

Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast - Investing.com

Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast Investing.com

Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts - Investing.com

Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts Investing.com

RSF executive relocates brain surgery medical company to Solana Beach - San Diego Union-Tribune

RSF executive relocates brain surgery medical company to Solana Beach San Diego Union-Tribune

CLPT Stock Price and Chart — NASDAQ:CLPT - TradingView

CLPT Stock Price and Chart — NASDAQ:CLPT TradingView

MRI Interventions to Exhibit its ClearPoint Neuro Intervention System at AANS 2014 Annual Meeting - GlobeNewswire

MRI Interventions to Exhibit its ClearPoint Neuro Intervention System at AANS 2014 Annual Meeting GlobeNewswire

Top Clearpoint Neuro, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant